Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2073 ARTÍCULOS , VIENDO DEL 1381 AL 1395

Alzheimer disease in the United States (2010-2050) estimated using the 2010 census

Hebert LE, Weuve J, Scherr PA, Evans DA.

Neurology. 2013 May 7;80(19):1778-83. doi: 10.1212/WNL.0b013e31828726f5. Epub 2013 Feb 6.

Dementia as a cultural metaphor

Zeilig H.

Gerontologist. 2014 Apr;54(2):258-67. doi: 10.1093/geront/gns203. Epub 2013 Feb 13.

Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden

Qiu C, von Strauss E, Bäckman L, Winblad B, Fratiglioni L.

Neurology. 2013 May 14;80(20):1888-94. doi: 10.1212/WNL.0b013e318292a2f9. Epub 2013 Apr 17.

Human culture and the future dementia epidemic: crisis or crossroads?

Whalley LJ, Smyth KA.

Neurology. 2013 May 14;80(20):1824-5. doi: 10.1212/WNL.0b013e318292a368. Epub 2013 Apr 17.

The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings

Wimo A, Reed CC, Dodel R, Belger M, Jones RW, Happich M, Argimon JM, Bruno G, Novick D, Vellas B, Haro JM.

J Alzheimers Dis. 2013;36(2):385-99. doi: 10.3233/JAD-122392.

Association between EXOC3L2 rs597668 polymorphism and Alzheimer's disease

Shang H, Fu J, Zhang XM, Song RR, Wang WZ.

CNS Neurosci Ther. 2013 Oct;19(10):834-9. doi: 10.1111/cns.12119. Epub 2013 May 11.

Personality and risk of Alzheimer's disease: new data and meta-analysis

Terracciano A, Sutin AR, An Y, O'Brien RJ, Ferrucci L, Zonderman AB, Resnick SM.

Alzheimers Dement. 2014 Mar;10(2):179-86. doi: 10.1016/j.jalz.2013.03.002. Epub 2013 May 21.

Intravenous immunoglobulin and Alzheimer's disease: what now?

Loeffler DA.

J Neuroinflammation. 2013 Jun 5;10:70. doi: 10.1186/1742-2094-10-70.

Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: analysis of effects of baseline features on treatment response

Sabbagh M, Cummings J, Christensen D, Doody R, Farlow M, Liu L, Mackell J, Fain R.

BMC Geriatr. 2013 Jun 6;13:56. doi: 10.1186/1471-2318-13-56.

Understanding placebo responses in Alzheimer's disease clinical trials from the literature meta-data and CAMD database

Ito K, Corrigan B, Romero K, Anziano R, Neville J, Stephenson D, Lalonde R.

J Alzheimers Dis. 2013;37(1):173-83. doi: 10.3233/JAD-130575.

Leveraging global resources to end the Alzheimer's pandemic

Carrillo MC.

Alzheimers Dement. 2013 Jul;9(4):363-5. doi: 10.1016/j.jalz.2013.05.1768.

What should we do if we were wrong and Alzheimer was right?

Breitner JC.

Int Psychogeriatr. 2014 Jan;26(1):3-6. doi: 10.1017/S1041610213001749. Epub 2013 Oct 18.

Alzheimer's disease

Oboudiyat C, Glazer H, Seifan A, Greer C, Isaacson RS.

Semin Neurol. 2013 Sep;33(4):313-29. doi: 10.1055/s-0033-1359319. Epub 2013 Nov 14.

Alzheimer disease: current concepts & future directions

Musiek ES, Schindler SE.

Mo Med. 2013 Sep-Oct;110(5):395-400.

C allele of the rs2209972 single nucleotide polymorphism of the insulin degrading enzyme gene and Alzheimer's disease in type 2 diabetes, a case control study

Gutiérrez-Hermosillo H, Díaz De León-González E, Palacios-Corona R, Cedillo-Rodríguez JA, Camacho-Luis A, Reyes-Romero MA, Medina-Chávez JH, Blandón PA.

Med Clin (Barc). 2015 Feb 20;144(4):151-5. doi: 10.1016/j.medcli.2013.09.035. Epub 2013 Dec 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias